San Francisco, CA4 Active Studies

Dravet Syndrome Clinical Trials in San Francisco, CA

Find 4 actively recruiting dravet syndrome clinical trials in San Francisco, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
527
Enrolling

Recruiting Dravet Syndrome Studies in San Francisco

NCT06872125Recruiting

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

The purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome....

San Francisco, CA170 participantsStoke Therapeutics, Inc
View Study Details
NCT06660394Recruiting

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

This (DEEp SEA Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and a...

San Francisco, CA160 participantsLongboard Pharmaceuticals
View Study Details
NCT04462770Recruiting

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole hydrochloride (EPX-100) as adjunctive therapy in children a...

San Francisco, CA150 participantsEpygenix
View Study Details
NCT05419492Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

ENDEAVOR is a Phase 1/2, 2-part, multicenter study to evaluate the safety and efficacy of ETX101 in participants with SCN1A-positive Dravet syndrome aged ≥6 to \<36 months (Part 1) and aged ≥6 to \<48...

San Francisco, CA47 participantsEncoded Therapeutics
View Study Details

About Dravet Syndrome Clinical Trials in San Francisco

Dravet syndrome is a rare, severe form of epilepsy that begins in the first year of life with prolonged seizures often triggered by fever. It is usually caused by mutations in the SCN1A gene. Treatment includes specific antiseizure medications, avoiding certain drugs that can worsen seizures, and investigational gene therapies.

There are currently 4 dravet syndrome clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 527 participants. Research is being sponsored by Stoke Therapeutics, Inc, Longboard Pharmaceuticals, Epygenix and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Dravet Syndrome Clinical Trials in San Francisco — FAQ

Are there dravet syndrome clinical trials in San Francisco?

Yes, there are 4 dravet syndrome clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What dravet syndrome treatments are being tested?

The 4 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for dravet syndrome.

Data updated July 13, 2026 from ClinicalTrials.gov